Results 171 to 180 of about 3,715,069 (278)
The SARS‐CoV‐2 papain‐like protease (PLpro) is a medicinal chemistry target. Here we report mass spectrometry assays employing oligopeptide substrates based on the sequences of the viral polyproteins 1a/1ab and on an ISG15‐modified human protein, which enabled the identification of substrate‐selective PLpro inhibitors.
Sakshi Sharma +13 more
wiley +1 more source
Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical Measurements. [PDF]
Ferreira CR +5 more
europepmc +1 more source
Combining the chiral bispidine ligand L1 with MnCl2 affords coordination polymers (CPs) with an unusual topology for this family of compounds, consisting of orthogonally packed ribbon‐like one‐dimensional (1D) chains. Their behavior was investigated through single‐crystal‐to‐single‐crystal exchange with aromatic volatile organic compounds (VOCs) and ...
Meriem Goudjil +8 more
wiley +1 more source
Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging. [PDF]
Sans M +9 more
europepmc +1 more source
Mild C─F Activation of Azido(per)Fluoroalkanes
Mild and selective activation of C(sp3)–F bonds in azido(per)fluoroalkanes using thiolates was developed, leading to novel functionalized azides. The reaction is initiated by nucleophilic attack of the sulfur atom to the terminal nitrogen of the azido group, followed by fluoride ion elimination.
Olena Shaitanova +7 more
wiley +1 more source
Metal‐Ion Regulated Light‐Free Z→E Isomerization of Azobenzene Glycomacrocycle
Metal ion‐catalyzed Z→E isomerization of photoswitchable azobenzene glycomacrocycle: A new azobenzene‐based glycomacrocycle is capable of forming a 1:1 complex with divalent metal ions in both E‐ and Z‐isomers. The complexes undergo light‐free Z→E isomerization in a timescale spanning from seconds to weeks.
Yang Zhou +4 more
wiley +1 more source
Control of Gemcitabine Activity With Blue and Red Light
Treating cancer with chemotherapy is generally associated with many side effects, which can be addressed by selectively releasing the desired drugs with visible light. Sixteen new blue light‐activatable cytostatics were introduced, with the gemcitabine derivative exhibiting ideal properties.
Nils F. Kersten +6 more
wiley +1 more source
Treatment of BINOL with a boron subphthalocyanine derivative resulted in the formation of a complex coordinated to an oxa[4]helicene derivative, which is generated via a ring‐closure reaction of BINOL. In contrast, treatment of the monomethyl ether of 1,1′‐bi‐2‐naphthol (BINOL) afforded the expected axially coordinated complex.
Shafikul Islam +5 more
wiley +1 more source
Bismuth Chalcogenide‐Based Photocatalysts for Nitrogen Reduction: Recent Progress and Prospects
Bismuth chalcogenides emerge as promising visible‐light photocatalysts for sustainable ammonia synthesis, driven by tunable electronic structures and strong N2 activation. Recent advances reveal how defects, doping and heterojunction design synergistically enhance charge separation and reactivity. Key challenges and future directions highlight pathways
Mukesh K. Verma +4 more
wiley +1 more source
Ru nanoparticles confined within mesoporous SiOx‐pillared montmorillonite exhibit exceptional performance for CO2 methanation. The catalyst maintains a high reaction rate even at elevated CO2 conversion while preserving high Ru mass–specific activity, overcoming typical inhibition by H2O and CO observed in conventional supported Ru catalysts.
Seunghwan Jung +4 more
wiley +1 more source

